下呼吸道感染病原体mNGS检测质量的多中心评估
该研究通过含人工微生物群落和真实临床样本的参考盘评估122家实验室mNGS检测下呼吸道感染病原体的性能,发现加权F1分数范围0.20–0.97,假阳性主要源于湿实验引入,假阴性主因湿实验微生物序列丢失,部分实验室能检出病原体但未能正确病因诊断。
要点
- 122家实验室mNGS检测性能差异大,加权F1分数0.20–0.97。
- 假阳性微生物68.56%(399/582)源于湿实验引入。
- 假阴性主因湿实验微生物序列丢失,占76.18%(275/361)。
核心结论
- 研究明确mNGS假阳性和假阴性的来源并评估结果解读能力,有助于实验室改进方法、避免错误报告并实施质控。
研究设计与样本
- 使用含人工微生物群落和真实临床样本的参考盘评估122家实验室的mNGS检测性能。
主要发现
- 122名参与者加权F1分数范围0.20至0.97。
- 假阳性微生物68.56%(399/582)由湿实验引入。
- 假阴性中76.18%(275/361)因湿实验微生物序列丢失。
- 人源背景为2×10^5 copies/mL时,>80%参与者可检出滴度>10^4 copies/mL的大部分DNA和RNA病毒。
- >90%实验室可检出滴度低于10^3 copies/mL的细菌和真菌。
临床怎么用
- 临床mNGS实验室应关注湿实验环节以减少假阳性和假阴性,并加强结果解读能力以避免错误病因诊断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Laboratory-developed metagenomic next-generation sequencing (mNGS) assays are increasingly being used for the diagnosis of infectious disease. To ensure comparable results and advance the quality control for the mNGS assay, we initiated a large-scale multicenter quality assessment to scrutinize the ability of mNGS to detect pathogens in lower respiratory infections. METHODS: A reference panel containing artificial microbial communities and real clinical samples was used to assess the performance of 122 laboratories. We comprehensively evaluated the reliability, the source of false-positive and false-negative microbes, as well as the ability to interpret the results. RESULTS: A wide variety of weighted F1-scores was observed across 122 participants, with a range from 0.20 to 0.97. The majority of false positive microbes (68.56%, 399/582) were introduced from "wet lab." The loss of microbial sequence during wet labs was the chief cause (76.18%, 275/361) of false-negative errors. When the human context is 2 × 105 copies/mL, most DNA and RNA viruses at titers above 104 copies/mL could be detected by >80% of the participants, while >90% of the laboratories could detect bacteria and fungi at titers lower than 103 copies/mL. A total of 10.66% (13/122) to 38.52% (47/122) of the participants could detect the target pathogens but failed to reach a correct etiological diagnosis. CONCLUSIONS: This study clarified the sources of false-positive and false-negative results and evaluated the performance of interpreting the results. This study was valuable for clinical mNGS laboratories to improve method development, avoid erroneous results being reported, and implement regulatory quality controls in the clinic.
引用
- Diao Z, Zhang Y, Chen Y, et al. Assessing the Quality of Metagenomic Next-Generation Sequencing for Pathogen Detection in Lower Respiratory Infections. Clin Chem. 2023. PMID: 37303219. doi:10.1093/clinchem/hvad072
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。